MetaCap

Coherus Oncology Insider Trades

NASDAQ: CHRSHealth CareBiotechnology: Biological Products (No Diagnostic Substances)USD

0.3698-0.0173 (-4.47%)

At close: Nov 20, 4:00 PM ET · Delayed 15 min

Last 12 months

Purchases
0 · $0
Sales
0 · $0
Shares bought / sold
0 / 0
Net activity
Net buying $0

Coherus Oncology insider activity

Over the last 12 months, Coherus Oncology insiders reported 11 transactions on SEC Form 4: 0 open-market purchases and 0 sales. The most recent filing shows Ryan Michael Lee (Director) reporting a transaction in 30,000 shares on Jun 5, 2026. Insider sales are common for compensation, tax and diversification reasons, while open-market purchases are rarer; tracking both helps put CHRS's ownership changes in context.

Summary generated from market data by MetaCap's automated system. Methodology

CHRS insider transactions

Coherus Oncology insider transactions
DateInsiderTypeSharesValueFiling
Jun 5, 2026Newton Charles W.DirectorAward30,000—Form 4
Jun 5, 2026Wahlstrom MatsDirectorAward30,000—Form 4
Jun 5, 2026Newcomer Lee NisleyDirectorAward30,000—Form 4
Jun 5, 2026Karachun Rita ADirectorAward30,000—Form 4
Jun 5, 2026Satvat Ali J.DirectorAward30,000—Form 4
Jun 5, 2026O'Donnell-Tormey JillDirectorAward30,000—Form 4
Jun 5, 2026Ryan Michael LeeDirectorAward30,000—Form 4
Jan 23, 2026Lanfear Dennis MPresident & CEOAward375,000—Form 4
Jan 22, 2026McMichael Bryan JChief Financial OfficerAward112,500—Form 4
Jan 20, 2026Lanfear Dennis MPresident & CEOTax withholding11,839$18.35KForm 4
Jan 20, 2026McMichael Bryan JChief Financial OfficerTax withholding1,715$2.66KForm 4
May 23, 2025Wahlstrom MatsDirectorSale99,988$73.88KForm 4
Jan 20, 2025Reider PaulChief Commercial OfficerTax withholding4,858$6.75KForm 4
Jan 20, 2025Lanfear Dennis MPresident & CEOTax withholding11,810$16.42KForm 4
Jan 20, 2025McMichael Bryan JChief Financial OfficerTax withholding1,711$2.38KForm 4
Jan 7, 2025McMichael Bryan JChief Financial OfficerTax withholding1,711$2.69KForm 4
Jan 4, 2025Lanfear Dennis MPresident & CEOTax withholding11,810$19.60KForm 4
Jan 4, 2025Reider PaulChief Commercial OfficerTax withholding2,277$3.78KForm 4
Dec 13, 2024Reider PaulChief Commercial OfficerTax withholding2,073$3.34KForm 4

Transaction codes follow SEC Form 4: P = open-market purchase, S = open-market sale, A = grant or award, M = option exercise, F = shares withheld for taxes. About Form 4

Related